A senior clinical development and research operations executive, Michael Clay has over 25 years of industry experience. His expertise spans the clinical research ecosystem, including site management, biopharma, and contract research organizations (CRO).
Michael served in multiple key leadership positions across the industry prior to joining Javara, most recently as Vice President of Cardiovascular, Metabolic & Critical Care and the Government and Public Health Services (GPHS) Unit Head at PPD. While there, he oversaw the portfolio of clinical development programs and led a large team of clinical trial professionals. Prior to that, Clay held several other executive and leadership positions during his 15 years with PPD, including Vice President of Strategic Business Operations and Vice President Clinical Development of Asia-Pacific where he managed teams from over 14 countries. Michael also brings significant experience in clinical site management having recently worked at Synexus USA as Chief Operations Officer, where he was responsible for operational delivery and quality oversight of over 85 clinical trial locations.
A thought leader and influential speaker, Michael has participated as a panelist at the MAGI conference and presented as the Keynote Speaker for both BioPharma Asia and the New Zealand Association of Clinical Research. While at PPD, Michael was a recognized leader executing multiple strategic growth initiatives for the organization and received multiple Leadership Awards for these achievements.
Michael received his M.S.J. in pharmaceutical and medical device law from Seton Hall University School of Law and a B.S. in biology from Missouri State University School of Natural and Applied Sciences.